CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 4 Open-market sale President sold 1,074 shares at $15.60 ($16,754)
- 4 Open-market sale Director sold 3,200 shares at $13.56 ($43,391)
- 4 Open-market sale EVP, QA & Regulatory Affairs sold 1,427 shares at $13.97 ($19,939)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,383 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale EVP, QA & Regulatory Affairs sold 21,244 shares at an average $12.89 ($273,774)
- 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 741 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Production gave up 568 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 614 shares (to pay taxes)
- 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,823 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 10,652 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & Chief Science Officer gave up 56,912 shares (to pay taxes)
- 4 Open-market sale Director sold 2,400 shares at $11.25 ($27,000)
- 4 Grant or award EVP, QA & Regulatory Affairs acquired 11,253 shares (grant or award)
- 4 Grant or award EVP, Production acquired 11,473 shares (grant or award)
- 4 Grant or award CFO, SVP & Treasurer acquired 39,717 shares (grant or award)
- 4 Grant or award President acquired 75,022 shares (grant or award)
Page 41 of 48 · 958 filings